Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | DGKA | P23743 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | F7 | P08709 | 2/20 | 0.35 |
| ▸ | F3 | P13726 | 2/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10081648 | 0.97 | ALDH1A1 (0.43) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL16607665 | 0.94 | DGKA (0.45) | ALDH1A1EPHX2MGLLDGKAMAPT | |
| SCHEMBL19169673 | 0.93 | DGKA (0.44) | ALDH1A1EPHX2MGLLDGKAMAPT | |
| SCHEMBL5030222 | 0.87 | LMNA (0.41) | ALDH1A1CYP3A4TSHRMGLLDGKA | |
| Water SCHEMBL6549696 | 0.80 | MGLL (0.46) | ALDH1A1EPHX2MGLLDGKAMAPT | |
| Hydrochloric Acid SCHEMBL4074680 | 0.80 | MGLL (0.46) | ALDH1A1EPHX2MGLLDGKAMAPT | |
| Hydrochloric Acid SCHEMBL421819 | 0.80 | MGLL (0.46) | ALDH1A1EPHX2MGLLDGKAMAPT | |
| SCHEMBL10081647 | 0.78 | EPHX2 (0.45) | ALDH1A1TDP1EPHX2MAPTCNR1 | |
| SCHEMBL5032814 | 0.77 | ALDH1A1 (0.46) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL19035810 | 0.77 | DEGS1 (0.35) | ALDH1A1EPHX2DGKACNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-06-08 | — | — | US | disclosed |
| US-9573884-B2 | Imidazoline amides and derivitives from natural oil metathesis | STEPAN COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| US-9573884-B2 | Imidazoline amides and derivitives from natural oil metathesis | STEPAN COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| EP-2632256-B1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-02-01 | — | — | EP | disclosed |
| US-20150376118-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2015-12-31 | — | — | US | disclosed |
| US-9175245-B2 | Fatty amides and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| US-9006144-B2 | Glyphosate formulations based on compositions derived from natural oil metathesis | STEPAN COMPANY (US) | 2015-04-14 | — | — | US | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| WO-2013162924-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130237421-A1 | GLYPHOSATE FORMULATIONS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY | 2013-09-12 | — | — | US | disclosed |
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| WO-2012061106-A1 | GLYPHOSATE FORMULATIONS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEHPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012061094-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | SGMS1, DEGS1, DGAT2 | ALDH1A1 671/4885CYP3A4 2038/4885ALOX15 41/4885 |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | DEGS1, SGMS1, DGAT2 | ALDH1A1 656/4885CYP3A4 2009/4885ALOX15 40/4885 |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | HHAT, AADAT, SQLE | ALDH1A1 2198/4885CYP3A4 3205/4885ALOX15 1312/4885 |
| US-20130237421-A1 | GLYPHOSATE FORMULATIONS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | DGAT2, DGAT1, GPR18 | ALDH1A1 4220/4885CYP3A4 3816/4885ALOX15 417/4885 |
| US-20150376118-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | DEGS1, SGMS1, DGAT2 | ALDH1A1 656/4885CYP3A4 2009/4885ALOX15 40/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.